Aspirin alone doesn’t seem to be enough to prevent symptomatic venous thromboembolism (VTE) in the months following total hip or knee replacement for osteoarthritis, results of the CRISTAL trial ...

Please provide your email address to receive an email when new articles are posted on . The proportion of patients receiving low-dose aspirin increased from 7.65% in 2012 to 55.29% in 2022. A low-dose ...

SAN DIEGO -- For patients with traumatic bone fractures, there was no difference between oral aspirin and low-molecular-weight heparin (LMWH) injections as a bleeding prevention strategy, a ...

The largest randomized controlled trial to date enrolled over 13,000 patients and evaluated whether or not aspirin is effective for the prevention of VTE in patients undergoing proximal femur or ...

Please provide your email address to receive an email when new articles are posted on . TAMPA, Fla. —Aspirin as a thromboprophylaxis agent was noninferior to low-molecular-weight heparin for all-cause ...

For patients with a variety of traumatic bone fractures, plain old oral aspirin provided just as good thromboprophylaxis as traditional low-molecular-weight heparin (LMWH) injections in the large ...

Healthcare is trending toward outpatient procedures, and technological advancements in surgical technique and pain management allow orthopedic surgeons to send their patients home within 24 hours of ...

President Trump takes a high daily dose of aspirin, and has done so for over two decades, rejecting medical guidelines and ...